OrphAI Therapeutics

Quick facts

Phase 2 pipeline

• Apilimod Dimesylate Capsule · Immunology
  Apilimod Dimesylate Capsule is a sphingosine 1-phosphate receptor modulator.
• LAM-001
• LAM-002A

Phase 1 pipeline

• Open Label LAM-003

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• OrphAI Therapeutics portfolio CI brief
• OrphAI Therapeutics pipeline updates RSS

Related

• Sector hub: All tracked pharma companies